NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD
Organigram Global Inc. (OGI) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 2 recommend buying, 2 recommend holding, and 1 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
